A ministerial ordinance modifying "the margin schedule of the pharmaceutical establishment which sells wholesale" was published in the Official Journal dated December 29, 2011 and takes effect as of January 1st 2012.

For reimbursable drugs, it provides for a single margin coefficient of 6.68% of the Producer's Price excluding taxes, with a minimum of ?0.30 and a maximum of ?30 per unit sold.

BOIRON, as a direct distributor of its drugs to pharmacists, is affected by this ordinance. The ordinance permits an increase in the selling price of a certain number of its reimbursable drugs for the first time in 23 years.

Next update: January 26th 2012, after the close of the stock market, publication of 2011 sales
Financial information manager: Philippe MONTANT
Contact for financial information: Véronique BOUSCAYROL
Investor relations: +33 (0) 4.78.45.63.43 - e-mail: finances@boiron.fr:
mailto:finances@boiron.fr
ISIN Code: FR0000061129 (BOI)  -  Bloomberg : BOI FP  -  Reuters : BOIR.PA
The group's financial information is online at : www.boiron.com

BOI CP GB 020112:
http://hugin.info/143375/R/1574667/490248.pdf


This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.

Source: BOIRON via Thomson Reuters ONE
HUG#1574667